Valéry Dambrin

Title: Valéry Dambrin: Innovator in Pharmaceutical Synthesis

Introduction

Valéry Dambrin is a notable inventor based in Montreuil Juigne, France. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of intermediates for important medications. His work exemplifies the intersection of chemistry and innovation, leading to advancements in drug formulation.

Latest Patents

Valéry Dambrin holds a patent for "Intermediates for the synthesis of (R)-tamsulosin and of its pharmaceutically acceptable salts and process for their preparation." This patent focuses on novel intermediates that are crucial for synthesizing (R)-tamsulosin, a medication used to treat benign prostatic hyperplasia. The associated preparation process outlined in the patent further enhances the efficiency of producing this important pharmaceutical compound.

Career Highlights

Dambrin is affiliated with Products Chimiques Auxiliaires et de Synthèse, where he applies his expertise in chemical synthesis. His career is marked by a commitment to advancing pharmaceutical chemistry and improving drug development processes. His innovative approach has led to the successful patenting of his work, showcasing his role as a key player in the industry.

Collaborations

Throughout his career, Valéry Dambrin has collaborated with esteemed colleagues such as Jean-Yves Lenoir and Jean-Marie Schneider. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of their research and development efforts.

Conclusion

Valéry Dambrin's contributions to pharmaceutical synthesis highlight his innovative spirit and dedication to improving drug formulation processes. His patent for intermediates in the synthesis of (R)-tamsulosin stands as a testament to his expertise and impact in the field.